Ocular surface disease is characterized by tear film instability and histopathologic and clinical changes of the ocular surface. Glaucoma patients often suffer from ocular surface disease caused by the chronic use of preserved medical treatment to reduce intraocular pressure. Benzalkonium chloride is the preservative most frequently used in glaucoma medications. Its effect on tear film, conjunctiva and cornea and the consequences in glaucoma management are discussed in this mini-review.
Keywords: Glaucoma; benzalkonium chloride; corneal modification; ocular surface disease; preservative; tear film..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.